Sourced from:Manufacturer Authorized Distributor
Quick Summary
Lagmitaf Tablet
Last updated on 03 Jul 2026 | 06:25 AM (IST)
₹2812
MRP: ₹5624
(You Save ₹2812)
30 TABLET(s) IN A BOTTLE
Lagmitaf Tablet is a prescription anticancer medicine used to treat certain types of cancer as advised by an oncologist. It contains an active targeted therapy that works by blocking specific pathways involved in the growth and spread of cancer cells. Lagmitaf is taken under strict medical supervision as part of a personalized cancer treatment plan.
Sourced from:Manufacturer Authorized Distributor
Lagmitaf Tablet
Salt Composition
BICTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDEMarketer
LAURUS LABS LTD
50% OFF
₹2812
MRP: ₹5,624.00
Inclusive of all taxes
50% Off
Salt Composition
BICTEGRAVIR,EMTRICITABINE,TENOFOVIR ALAFENAMIDEMarketer
LAURUS LABS LTD
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Jasbuzz Tablet
JASGUR LIFE SCI...
₹ 47.83/tablet
48% cheaper
3 Mune Tablet
CIPLA LTD
₹ 69.60/tablet
25% cheaper
Alcibicla Tablet
MYLAN PHARMACEU...
₹ 73.33/tablet
21% cheaper
Taftrio Tablet
HETERO HEALTHCA...
₹ 97.50/tablet
5% costlier
Introduction
Lagmitaf Tablet is an antiretroviral drug containing the active ingredient Bictegravir, Emtricitabine, and Tenofovir Alafenamide. It is used in the treatment of HIV-1 infection. It is a Human immunodeficiency virus that mainly occurs when a person's immune system is attacked and weakened by the human immunodeficiency virus (HIV). This infection progressively weakens the immune system, making individuals more susceptible to opportunistic infections.
Do not take Lagmitaf Tablet if you are allergic to Bictegravir, Emtricitabine, Tenofovir Alafenamide, and other ingredients. During the early stages of HIV-1 treatment, some patients may experience an inflammatory response to opportunistic infections. This condition is called immune reconstitution syndrome. It can occur after starting the drug or other antiretroviral therapies. Knowing this possibility and monitoring for any signs of worsening infections or inflammatory symptoms is necessary. Report to your doctor if you have had a history of heart failure, pancreatitis, bone disease, fractures, liver or kidney problems. Patients diagnosed with pancreatitis or at risk of pancreatitis should take this combination of medicine cautiously. During the treatment with Lagmitaf Tablet, your doctor may periodically monitor your blood counts, bone mineral density, and liver and kidney parameters to prevent serious complications.
Adults of childbearing potential should consider using an effective contraceptive to prevent unwanted pregnancy. If you are pregnant or think you might be pregnant, your physician might suggest an alternative treatment, as this combination regimen is not recommended during early pregnancy. Breastfeeding is not recommended due to the possible transmission of HIV-1 infection from the mother to the baby. It's necessary to inform your doctor about all your medications, including prescription, over-the-counter, and herbal supplements, to ensure no potential interactions. Lagmitaf tablet price affordable is in MrMed.
Uses
Lagmitaf Tablet uses:
Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection
How Lagmitaf Tablet Works
Lagmitaf Tablet combine integrase strand transfer inhibitors and nucleoside, nucleotide analogue reverse transcriptase inhibitors. It increases the number of CD4 T cells and stimulates the immune system to fight against infections. Thereby, it reduces the viral load of HIV in the blood and decreases the severity of HIV infection.
Interaction of Lagmitaf Tablet with other drugs
Rifampicin (Oral Route) Life-threatening
Do not use together.
Concomitant use may greatly reduce the blood levels of bictegravir and tenofovir, making the HIV treatment ineffective.
Carbamazepine, Phenytoin, or Phenobarbital (Oral Route) Life-threatening
Avoid using together.
These medicines may lower the levels of bictegravir in the body and reduce the effectiveness of the treatment.
St. John’s Wort (Herbal Route) Life-threatening
Do not take together.
This herbal product may decrease the effect of the medicine and lead to treatment failure.
Antacids containing Aluminium or Magnesium (Oral Route) Moderate
Take with caution and keep a time gap.
These products may reduce the absorption of bictegravir and lower its effectiveness.
Other antiretroviral medicines containing Tenofovir or Emtricitabine (Oral Route) Moderate
Use only if prescribed.
Taking similar medicines together may increase the risk of side effects without added benefit.
Storage Conditions
Store Lagmitaf Tablet at room temperature below 30°C.
Keep out of sight and reach of pets and children.
How to consume Lagmitaf Tablet
Take the Lagmitaf Tablet as advised by your physician. Swallow the tablets whole and intact. This tablet should be taken with food. Do not crush, chew, or open the medicine. Your physician will decide the correct lagmitaf tablet dose and duration based on age, body weight, and disease condition. Only stop taking the medicine if your doctor advises you to stop.
Safety Advice
Breast Feeding
Breastfeeding is not recommended in patients taking Lagmitaf Tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Alcohol
It is unsafe to consume alcohol while taking Lagmitaf Tablet. It may reduce the drug's effectiveness and can cause toxic side effects.
Liver
Lagmitaf Tablet must be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary for severe liver failure. Inform your doctor if you have liver problems before initiating the therapy.
Lungs
It is unknown whether Lagmitaf Tablet are safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Driving
Lagmitaf Tablet can make you feel dizzy and affect your concentration. Do not drive or operate machinery.
Pregnancy
Consult your doctor if you are pregnant or planning for pregnancy during the treatment with Lagmitaf Tablet.
Side Effects
Lagmitaf Tablet side effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them.
Serious side effects of the Lagmitaf Tablet are:
Bone loss
Worsening of Hepatitis B
Kidney injury
Immune reconstitution syndrome
Lactic acidosis
Liver toxicity
Common side effects of the Lagmitaf Tablet are:
Depression
Abnormal dreams
Headache
Dizziness
Diarrhea
Feeling sick (Nausea)
Tiredness (Fatigue)
Expert Tips
Do not share needles, syringes, or personal items like toothbrushes and razors, as these can transmit HIV through blood or body fluids.
Always practise safe sex and use a latex or polyurethane condom to reduce the risk of infection.
If you miss a dose, take your usual dose the next day, but never take a double dose.
Store the tablets in a dry place, away from moisture, and keep them in a tightly closed container.
Do not use this medicine for other conditions or share it with others, even if they have similar symptoms.
FAQs
Q1.
What should you not take with the Lagmitaf Tablet?
Taking Lagmitaf Tablet with antacids is not recommended. Tell your healthcare provider about taking other medications, over-the-counter drugs, vitamins, or herbal supplements.
Q2.
What are the symptoms of lactic acidosis?
Unusual weakness, tiredness, muscle pain, trouble breathing, stomach pain, nausea, vomiting, dizziness, lightheadedness, irregular heartbeat, and cold are lactic acidosis's most prominent symptoms.
Q3.
What are some of the long-term side effects of the Lagmitaf Tablet?
Some serious side effects of this combination regimen include worsening hepatitis B, bone loss, kidney injury, pancreatitis, immune reconstitution syndrome, liver toxicity, and hypersensitivity reactions.
Q4.
What should you do if you miss a dose of Lagmitaf Tablet?
If you missed a dose of Lagmitaf Tablet, take one tablet as soon as you remember. However, if it is almost time for your next dose, skip this dose and take your next dose as per schedule. Do not double the dose to compensate for the missed dose.
Q5.
What are the required laboratory parameters before starting this treatment with Lagmitaf Tablet?
If you are an adolescent or adult of childbearing potential, your healthcare provider will perform a pregnancy test before prescribing this treatment. Other prominent tests for HBV infection are serum creatinine, estimated creatinine clearance, urine glucose, and urine protein.
Q6.
How to store Lagmitaf Tablet?
Store Lagmitaf Tablet at room temperature in a tightly closed container away from the reach of children.
Q7.
If I have difficulty swallowing, How do I take Lagmitaf Tablet?
If you have problems swallowing the Lagmitaf Tablet, split the tablet into two and take them separately within 10 minutes.
Fact Box
Molecule Name: | Bictegravir, Emtricitabine, Tenofovir Alafenamide |
Therapeutic class: | Antiretroviral |
Pharmacological class: | 1. Bictegravir-Integrase strand transfer inhibitor (INSTI) 2.Emtricitabine-Nucleoside reverse transcriptase inhibitor (NRTI) 3.Tenofovir Alafenamide-Nucleotide reverse transcriptase inhibitor (NtRTI) |
Indication: | Treatment of human immunodeficiency virus 1 (HIV-1) infection |
References
- Gilead Sciences Inc., U.S. Food and Drug Administration (EMC), [Revised on Oct 2021] [Accessed on 20th May 2023], https://www.medicines.org.uk/emc/files/pil.9313.pdf
- KD Tripathi, Antiviral Drugs (Anti-retrovirus), Essentials of Medical Pharmacology, 8th Edition, 2019, 860-872.
- Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Antiretroviral agents and treatment of HIV infection, 12th Edition, 2011, 1634-1638.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
P. Thirumal Reddy
B. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 03 Jul 2026 | 06:25 AM (IST)
Want to know more?
Read Our Editorial Policy